Biopharma M&A activity jumped 71% in Q1 2024

Biopharma mergers and acquisitions (M&A) activity is ratcheting back up following a downturn in 2022 and 2023.

Biopharma M&A have increased by 71% year-over-year during the first quarter of 2024, according to a report out of GlobalData this week.